Mesenchymal Cell News Volume 14.29 | Jul 26 2022

    0
    28








    2022-07-25 | MESCN 14.29


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.29 – 26 July, 2022
    TOP STORY

    Engineered Immunomodulatory Accessory Cells Improve Experimental Allogeneic Islet Transplantation without Immunosuppression

    Researchers engineered programmed death ligand-1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein–modified MSCs as accessory cells for islet cotransplantation.
    [Science Advances]

    Full Article
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    PUBLICATIONSRanked by the impact factor of the journal

    Mesenchymal Stem Cells Derived from Adipose Accelerate the Progression of Colon Cancer by Inducing a MT-CAFs Phenotype via TRPC3/NF-KB Axis

    Scientists explored the function and mechanism of MSC-transformed cancer associated fibroblasts cells (MT-CAFs) on progression of colon cancer.
    [Stem Cell Research & Therapy]

    Full Article

    A Cell Penetrating Peptide-Modified Magnetic/Fluorescent Probe for In Vivo Tracking of Mesenchymal Stem Cells

    Paramagnetic element-doped upconversion nanoparticles’ potential in cell labeling and in vivo tracking applications was comprehensively explored.
    [Journal of Biomedical Materials Research Part A]

    Abstract

    Three-Dimensional Culture of Equine Bone Marrow-Derived Mesenchymal Stem Cells Enhances Anti-Inflammatory Properties in a Donor-Dependent Manner

    Researchers evaluated the feasibility, cell viability, and stem cell marker stability of 3D-cultured equine bone marrow-derived MSCs and determined the effect of inflammatory stimulation upon gene expression and secretion of key regulators of inflammation.
    [Stem Cells and Development]

    Abstract

    Scanning Probe Microscopy Bone Marrow Determination of Steogenic Differentiation of Mesenchymal Stem Cells

    To address the question of determining the osteogenic differentiation of MSCs, bone marrow studies were performed using probe microscopy.
    [Contrast Media & Molecular Imaging]

    Abstract

    How to Maintain and Transport Equine Adipose Tissue for Isolating Mesenchymal Stem Cells?

    The authors evaluated the impact of tissue maintenance under different conditions on MSCs derived from adipose tissue.
    [BMC Veterinary Research]

    Full Article

    Static and Electromagnetic Fields Differently Affect Proliferation and Cell Death Through Acid Enhancement of ROS Generation in Mesenchymal Stem Cells

    Scientists investigated the effects of the static magnetic field and electromagnetic field on reactive oxygen species (ROS) production and the acidic pH conditions as stimuli to change cell cycle progression and cell death in MSCs.
    [Radiation Research]

    Abstract

    Metabolic Switching of Cultured Mesenchymal Stem Cells Creates Super Mitochondria in Rescuing Ischemic Neuron

    MSCs were grown under ambient conditions or a metabolic switching paradigm by alternating galactose and glucose in medium and then assayed for oxygen consumption rates using the Seahorse technology.
    [Neuromolecular Medicine]

    Full Article

    PTEN and LKB1 Are Differentially Required in Gli1-Expressing Mesenchymal Cells to Suppress Gastrointestinal Polyposis

    Investigators revealed that PTEN or LKB1 deficiency in Gli1+ gut mesenchymal cells, but not intestinal epithelium, drove polyp formation histologically resembling polyposis in human patients.
    [Cell Reports]

    Full ArticleGraphical Abstract
    Listen to the Stem Cell Podcast episodes covering ISSCR 2022 sessions.
    REVIEWS

    Mesenchymal Stromal Cells as a Tool to Unravel the Developmental Origins of Disease

    MSCs may serve as a novel tool to investigate the full epigenome beyond DNA methylation, to explore other omics levels, and to perform functional assays.
    [Trends in Endocrinology and Metabolism]

    Full Article

    Mesenchymal/Stromal Stem Cells: Necessary Factors in Tumour Progression

    Exosomes, as communicators, carry various RNAs and proteins and thus link MSCs and the tumor microenvironment, which provides options for improving outcomes and developing targeted treatment.
    [Cell Death Discovery]

    Full Article

    The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus

    Investigators review current findings regarding the immunomodulatory and regenerative mechanisms of MSCs, as well as their therapeutic applications in diabetes mellitus (DM) and DM-related complications.
    [Cellular Reprogramming]

    Abstract
    INDUSTRY AND POLICY NEWS

    US FDA Approves QBiotics Investigational New Drug Application to Initiate Tigilanol Tiglate Soft Tissue Sarcoma Phase II Trial

    QBiotics Group Limited has been granted approval of its Investigational New Drug application by the US FDA for lead oncology molecule, tigilanol tiglate.
    [QBiotics Group Limited]

    Press Release
    FEATURED EVENT

    Cell UK

    November 7 – 8, 2022
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Cancer Biology and Immunotherapies

    Sanford Research – Sioux Falls, South Dakota, United States

    Postdoctoral Researcher – Microfluidics, Organoids, and Precision Medicine

    Lehigh University – Bethlehem, Pennsylvania, Untied States

    Director – Bone & Soft Tissue Pathology

    Michigan Medicine – Ann Arbor, Michigan, United States

    Associate Professor – Thematic Research Programs

    The Chinese University of Hong Kong – Hong Kong, China

    Postdoctoral Position – Combined Omics

    UT Health Science Center at San Antonio – San Antonio, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter